PA8592501A1 - Complejos de e-2-metoxi-n-(3-{4-[3-metil-4(6-metilpiridin-3-iloxi)fenilamino]quinazolin-6-il}alil)acetamida, su procedimiento de produccion y uso - Google Patents

Complejos de e-2-metoxi-n-(3-{4-[3-metil-4(6-metilpiridin-3-iloxi)fenilamino]quinazolin-6-il}alil)acetamida, su procedimiento de produccion y uso

Info

Publication number
PA8592501A1
PA8592501A1 PA20038592501A PA8592501A PA8592501A1 PA 8592501 A1 PA8592501 A1 PA 8592501A1 PA 20038592501 A PA20038592501 A PA 20038592501A PA 8592501 A PA8592501 A PA 8592501A PA 8592501 A1 PA8592501 A1 PA 8592501A1
Authority
PA
Panama
Prior art keywords
complexes
methylpiridin
iloxi
metoxi
alil
Prior art date
Application number
PA20038592501A
Other languages
English (en)
Inventor
Zheng Jane Li
Jason Albert Leonard
Andrew Vincent Trask
John Charles Kath
Daniel Tyler Richter
Carl Brian Thomson
Joel Morris
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8592501A1 publication Critical patent/PA8592501A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A COMPLEJOS DE E-2-METOXI-N(3-{4-[3-METIL-4-(6-METILPIRIDIN-3-IlOXI)FENILAMINO]QUINAZOLIN-6-Il}AlIl)ACETAMIDA QUE TIENEN LA SIGUIENTE FORMULA 1: FORMULA 1 LA INVENCION SE REFIERE TAMBIEN A COMPOSICIONES FARMACEUTICAS QUE CONTIENEN LOS COMPLEJOS DE FORMULA 1. LA INVENCION SE REFIERE ADEMAS A PROCEDIMIENTOS DE TRATAMIENTO DE ENFERMEDADES HIPERPROLIFERATIVAS, TALES COMO CANCERES, EN MAMIFEROS, ESPECIALMENTE SERES HUMANOS, ADMISTRANDO LOS COMPLEJOS ANTERIORES Y A PROCEDIMIENTOS DE PREPARACION DE LOS COMPLEJOS ANTERIORES.
PA20038592501A 2002-12-19 2003-12-15 Complejos de e-2-metoxi-n-(3-{4-[3-metil-4(6-metilpiridin-3-iloxi)fenilamino]quinazolin-6-il}alil)acetamida, su procedimiento de produccion y uso PA8592501A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43470002P 2002-12-19 2002-12-19

Publications (1)

Publication Number Publication Date
PA8592501A1 true PA8592501A1 (es) 2004-09-16

Family

ID=32682089

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20038592501A PA8592501A1 (es) 2002-12-19 2003-12-15 Complejos de e-2-metoxi-n-(3-{4-[3-metil-4(6-metilpiridin-3-iloxi)fenilamino]quinazolin-6-il}alil)acetamida, su procedimiento de produccion y uso

Country Status (21)

Country Link
US (1) US20050075354A1 (es)
EP (1) EP1575936A1 (es)
JP (1) JP2006512355A (es)
KR (1) KR20050085835A (es)
CN (1) CN1726208A (es)
AR (1) AR042508A1 (es)
AU (1) AU2003283743A1 (es)
BR (1) BR0317259A (es)
CA (1) CA2509140A1 (es)
GT (1) GT200300287A (es)
MX (1) MXPA05006582A (es)
NL (1) NL1025072C2 (es)
NO (1) NO20052803L (es)
PA (1) PA8592501A1 (es)
PE (1) PE20040915A1 (es)
PL (1) PL377533A1 (es)
RU (1) RU2005122659A (es)
TW (1) TW200424191A (es)
UY (1) UY28129A1 (es)
WO (1) WO2004056802A1 (es)
ZA (1) ZA200504621B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192298A1 (en) * 2004-02-27 2005-09-01 Pfizer Inc Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide
JP2008542356A (ja) * 2005-06-03 2008-11-27 ファイザー・プロダクツ・インク 異常な細胞増殖の治療用の二環式誘導体
DK3150610T3 (da) 2010-02-12 2019-11-04 Pfizer Salte og polymorfer af 8-fluor-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-on
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884418B1 (en) * 1989-08-04 2005-04-26 Berlex Laboratories, Inc. Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy
HUP0301120A2 (hu) * 2000-06-22 2003-08-28 Pfizer Products Inc. Szubsztituált fenilamino-kinazolin-származékok, alkalmazásuk rendellenes sejtnövekedés kezelésére és azokat tartalmazó gyógyszerkészítmények
DE60223279T2 (de) * 2001-11-30 2008-05-29 Osi Pharmaceuticals, Inc. Verfahren für die herstellung substituierter bicyclischer derivate zur behandlung von anomalem zellwachstum
BR0214499A (pt) * 2001-12-12 2005-05-10 Pfizer Prod Inc Derivados de quinazolina para o tratamento do crescimento anormal das células
JP4202926B2 (ja) * 2001-12-12 2008-12-24 ファイザー・プロダクツ・インク Ｅ−２−メトキシ−ｎ−（３−（４−（３−メチル−ピリジン−３−イロキシ）−フェニルアミノ）−キナゾリン−６−イル）−アリル）−アセトアミドの塩形態、その製造および癌に対するその使用

Also Published As

Publication number Publication date
AR042508A1 (es) 2005-06-22
CA2509140A1 (en) 2004-07-08
CN1726208A (zh) 2006-01-25
NL1025072C2 (nl) 2007-07-24
PE20040915A1 (es) 2005-01-18
GT200300287A (es) 2004-11-30
EP1575936A1 (en) 2005-09-21
AU2003283743A1 (en) 2004-07-14
JP2006512355A (ja) 2006-04-13
MXPA05006582A (es) 2005-08-16
KR20050085835A (ko) 2005-08-29
UY28129A1 (es) 2004-07-30
ZA200504621B (en) 2006-03-29
WO2004056802A1 (en) 2004-07-08
PL377533A1 (pl) 2006-02-06
BR0317259A (pt) 2005-11-08
NO20052803D0 (no) 2005-06-09
TW200424191A (en) 2004-11-16
NL1025072A1 (nl) 2004-06-22
US20050075354A1 (en) 2005-04-07
RU2005122659A (ru) 2006-01-20
NO20052803L (no) 2005-09-16

Similar Documents

Publication Publication Date Title
CY1116103T1 (el) Υποκατεστημενα παραγωγα 1,2,3,4-τετραϋδροϊσοκινολινης
BR0108678A (pt) Novos compostos
PT1326643E (pt) Inibicao do efeito emetico da metformina com antagonistas de receptores 5-ht3
SE0102438D0 (sv) New compounds
MEP53708A (en) 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl) -n-methyl -amino) -anilino)-1- phenyl-methylene] -6-methoxycarbonyl -2-indolinone -monoethanesulphonate and the use thereof as a pharmaceutical composition
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
AR037772A1 (es) Formas de sal e-2-metoxi-n-(3-{4-[3-metil-4-(6-metilpiridin-3-iloxi)fenilamino]quinazolin-6-il]alil)acetamida y procedimiento de produccion
SE0200979D0 (sv) New compounds
EA200700192A1 (ru) Производные фталазина в качестве ингибиторов parp
SE0101387D0 (sv) Novel compounds
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
SE9904505D0 (sv) Novel compounds
ECSP066314A (es) Derivados piridilo y su uso como agentes terapéuticos
AR029463A1 (es) Pirrolidinas disustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de un medicamento
ECSP088283A (es) Compuestos de piridina 5- (fenilisoxazoliletoxi) -triazol- 3-ilo substituidos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor
SE0100569D0 (sv) New compounds
BRPI0409454A (pt) compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com o receptor de glucagon e sua utilização
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
SE0501903L (sv) Borföreningar användbara vid BNCT
TW200800984A (en) New compounds
BRPI0415203A (pt) pentanóis reestruturados, um processo para sua produção e seu uso como agentes antiinflamatórios
SE0102440D0 (sv) New compound
PA8592501A1 (es) Complejos de e-2-metoxi-n-(3-{4-[3-metil-4(6-metilpiridin-3-iloxi)fenilamino]quinazolin-6-il}alil)acetamida, su procedimiento de produccion y uso
SE0401655D0 (sv) New compounds